Medical Oncologist
Hyderabad's Dedicated Liver Cancer Network · NCCN Protocols · 11 City Centres + 35 Partner Centres
Best Liver Cancer Hospital in Hyderabad — 11 Centres, NCCN Protocols, NABH-Accredited Partners
Choosing a liver cancer hospital isn't about picking a building — it's about choosing the team, the protocols, and the infrastructure that will sequence your treatment correctly across surgery, ablation, embolization, and systemic therapy. CION runs Hyderabad's dedicated liver cancer network: 11 city centres, NCCN-protocol care for HCC and cholangiocarcinoma, and NABH-accredited partners for liver transplant, TACE, TARE, and RFA.
- 11 city centres + 35 partner centres — same panel and protocols across Telangana & Andhra Pradesh
- 1,000+ liver cancer cases / year — managed network-wide, tumour-board reviewed with BCLC staging
- NABH-accredited partners — for liver transplant, TACE, TARE / Y-90 SIRT, RFA & SBRT
- Free written second opinion — 45-minute consultation, BCLC staging, treatment plan — yours to keep
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
The CION Liver Cancer Panel
Surgical, medical & radiation oncology — one team. Hepatobiliary-led, tumour-board reviewed.
Every CION liver cancer case is managed by the hepatobiliary panel below - surgical oncology, medical oncology, radiation oncology, plus partner-coordinated interventional radiology. Hepatectomy, ablation, TACE, TARE, and current NCCN systemic regimens run through a single tumour board. Use the tabs to filter by specialty; request a specific doctor by name when booking.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
How to Choose a Liver Cancer Hospital
Why the hospital matters more than the building
Most patients begin by searching for the best liver cancer doctor in Hyderabad. The doctor matters — but the doctor works inside a system. Liver cancer treatment depends on more than surgical skill: BCLC staging requires multi-phase CT or MRI with LI-RADS reporting, AFP testing, and an honest assessment of liver function. Decisions between resection, transplant, ablation, embolization, radiation, and systemic therapy demand an interventional radiology suite, a hepatology service for cirrhosis management, and a transplant pathway when Milan criteria apply. A hospital missing any one of these pieces forces compromises a tumour board would never accept.
This page gives you an honest framework — eight institutional signals that separate hospitals that can manage liver cancer well from hospitals that simply offer the service — and explains how CION is built around them. Use the framework on every hospital you shortlist. If a hospital can't answer in writing, it should fall off your list.
Did you know?
For early-stage HCC treated with curative options — resection, ablation, or liver transplant within Milan criteria — 5-year survival commonly reaches 50–70%, and post-transplant survival can exceed 70%. Once liver cancer reaches advanced stages, median survival with first-line systemic therapy is measured in months. Early diagnosis through structured surveillance in patients with cirrhosis or chronic hepatitis B is the single highest-leverage decision in liver cancer outcomes. Per US National Cancer Institute SEER data, 5-year relative survival for liver cancer is approximately 37% for localised disease, 13% for regional spread, and 4% for distant metastasis — making early diagnosis the single most important factor in your outcome.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
The 8-Criteria Decision Framework
8 things that make a hospital genuinely the best for liver cancer in Hyderabad
These are the eight institutional signals oncology audit teams use. Each is verifiable. Each is non-negotiable. Ask the question, get it in writing, and walk away if you can't.
A hepatobiliary-trained multidisciplinary team
Liver cancer is surgery + ablation + embolization + radiation + systemic therapy, sequenced by stage and liver function. The team needs a surgical oncologist or hepatobiliary surgeon trained in major hepatectomy, a medical oncologist running atezolizumab + bevacizumab, lenvatinib, and sorafenib protocols, a radiation oncologist comfortable with SBRT, access to interventional radiology for TACE/TARE/RFA, a hepatologist for cirrhosis management, and a pathologist with experience in HCC and cholangiocarcinoma biopsies. Ask for named team credentials in writing.
Walk away if the hospital cannot name who manages your cirrhosis and who reviews your imaging before surgery.Tumour-board review with BCLC staging, on every case
A liver cancer tumour board reviews multi-phase imaging, AFP trend, Child-Pugh score, and any biopsy together — surgical, medical, radiation oncology, interventional radiology, hepatology, and pathology — and issues a written, agreed treatment plan staged by BCLC. The board debates resection vs ablation vs transplant vs TACE vs systemic therapy for every case.
Walk away if surgery is scheduled in the first consultation without a documented BCLC staging discussion.Annual hepatectomy surgical volume — in writing
Major hepatectomy is one of the most technically demanding general surgical operations. Hospital volume predicts outcomes: lower 30-day mortality, lower bile leak rates, lower post-hepatectomy liver failure, and better 90-day survival. Ask: "How many hepatic resections did your team perform last year? How many were major (≥3 segments)? What is your 90-day mortality?" Specific numbers indicate transparency.
Walk away if volume is described as "many" — no specific number offered.Multi-phase imaging, AFP, and biopsy infrastructure
HCC diagnosis in a cirrhotic liver is made by imaging in many cases — multi-phase contrast CT or MRI with arterial enhancement and washout, reported using the LI-RADS system. Where imaging is equivocal or for cholangiocarcinoma, an image-guided biopsy is essential. AFP supports diagnosis and surveillance. For ICC, FGFR2 fusion, IDH1, HER2, and BRAF testing open targeted therapy options.
Walk away if your imaging is reviewed without LI-RADS categorisation or your treating team can't explain your BCLC stage.Day-care systemic therapy close to home
Advanced HCC is managed with atezolizumab + bevacizumab (the IMbrave150 first-line standard), lenvatinib or sorafenib (TKIs), and second-line options including pembrolizumab, nivolumab, and durvalumab + tremelimumab. ICC is managed with gemcitabine + cisplatin, increasingly with durvalumab (TOPAZ-1). Each cycle is a multi-hour infusion or oral dosing with frequent oncologist review.
Walk away if all systemic therapy is administered at one campus only.NABH-accredited partners for transplant, TACE, TARE, RFA & SBRT
Liver cancer treatment routinely calls on procedures that need specialised infrastructure — liver transplantation for Milan-criteria HCC, TACE and TARE/Y-90 SIRT through an interventional radiology suite, percutaneous RFA or microwave ablation for small lesions, and SBRT through linear accelerators with motion management. NABH-accredited partners signal audited surgical and procedural safety.
Walk away if the hospital says "we'll refer you out if needed" but cannot name the transplant centre, IR suite, or accreditation status.Insurance, ArogyaSri & TPA empanelment in writing
Liver cancer treatment can range from a single TACE session to a liver transplant — and the financial profile varies by an order of magnitude. A hospital that isn't empanelled for your insurance or ArogyaSri at the specific centre where your procedure happens can derail planning at the worst moment. Transplant in particular has scheme-specific rules.
Walk away if cost estimates change after admission — a serious hospital writes them down beforehand.Continuity of care and cirrhosis surveillance
Most HCC patients also have cirrhosis, and surveillance continues lifelong — 6-monthly ultrasound or MRI plus AFP, plus management of the underlying liver disease (hepatitis B antivirals, hepatitis C cure, alcohol cessation support, NASH/MASLD management). You will see your team frequently. A hospital an hour away makes every visit a half-day; a network of centres close to home — same panel, same protocols, shared records — makes continuity sustainable.
Walk away if you're told you must travel to one campus for every surveillance appointment for the next five years.If a hospital can't answer all eight in writing, it should fall off your shortlist. Bring this framework to every consultation — ours or anyone else's.
Hospital Archetype Comparison
Cancer-specialty network vs multi-specialty hospital vs Ayurveda
Hyderabad has all three models. They are not interchangeable. The right one depends on your stage, your liver function, and whether you are a transplant candidate. Here's an honest comparison.
| Hospital archetype | Strengths for liver cancer | Trade-offs | Best fit for |
|---|---|---|---|
| Dedicated cancer-specialty hospital or network | Tumour-board review with BCLC staging. Day-care systemic therapy infrastructure. Tight oncology coordination. Partner pathway for transplant, TACE, TARE, RFA, and SBRT. | Liver transplant and complex interventional radiology coordinated through partners. Strong networks solve this with NABH-accredited tie-ups. | Most liver cancer patients — BCLC A, B, and C disease where multidisciplinary oncology and systemic therapy continuity matter. |
| Multi-specialty general hospital with transplant programme | In-house liver transplant team. In-house hepatology, interventional radiology, and intensive care. Single-campus convenience for complex cases. | Oncology depth varies. Systemic therapy day-care may not be oncology-dedicated. Tumour-board cadence varies. | Active transplant candidates within Milan criteria, or patients with advanced cirrhosis needing in-house hepatology and ICU support. |
| Ayurveda hospital | Symptom palliation and post-treatment recovery support. Some patients value the holistic framing. | Not evidence-based as primary curative treatment. Should never delay resection, ablation, transplant, or systemic therapy in liver cancer. | Strictly as an add-on to allopathic oncology care. Discuss any Ayurveda use openly with your medical oncologist — many herbal preparations interact with TKIs and the cirrhotic liver. |
The structurally correct default for most non-transplant liver cancer patients is a dedicated cancer-specialty hospital or network with NABH-accredited partners for transplant and loco-regional therapy — which is precisely how CION is built.
The Institutional Answer
How CION is built for liver cancer at an institutional level
CION is not a single hospital. It is a dedicated cancer-specialty network — 11 centres across Hyderabad and 35+ partner centres across Telangana and Andhra Pradesh — with the same panel of oncologists, the same NCCN protocols, and the same tumour-board governance at every site. The network is architected specifically around the eight signals above.
A network architecture, not a building
Hospital infrastructure for liver cancer is tiered at CION. Multi-phase imaging, AFP surveillance, day-care systemic therapy, and follow-up consultations happen at the centre nearest your home. Hepatic resection, radiation, and partner-coordinated procedures — TACE, TARE, RFA, SBRT, and liver transplant — run from the surgical pathway through NABH-accredited partners. The same oncology team that consults at one centre stays with you across the network.
Multi-phase imaging and AFP across six city centres
CT, MRI, and PET-CT imaging — including multi-phase contrast protocols required for LI-RADS reporting — are available across six CION centres in Hyderabad. AFP testing runs through integrated lab pathways. Imaging is reviewed by treating oncologists alongside the CION pathology and interventional radiology partner teams, with turnaround designed to keep BCLC-stage-based treatment on schedule.
Full molecular workup for cholangiocarcinoma and selected HCCs
Cholangiocarcinoma cases at CION get the molecular panel that NCCN and ESMO guidelines recommend: FGFR2 fusion, IDH1, HER2, and BRAF testing through integrated lab pathways. FGFR2-fusion-positive cholangiocarcinoma may qualify for pemigatinib or infigratinib; IDH1-mutant tumours may qualify for ivosidenib. For HCC, molecular profiling is increasingly used in selected cases. Molecular guidance is not optional in 2026 — it is the standard of care.
NCCN-protocol systemic therapy at every centre
All 11 CION centres in Hyderabad have day-care infusion bays. Atezolizumab + bevacizumab, lenvatinib, sorafenib, durvalumab + tremelimumab, pembrolizumab, nivolumab, and gemcitabine + cisplatin regimens for HCC and ICC are administered close to home. Oncology-trained nursing, infusion-reaction protocols for biologics, and on-site oncologist supervision are standard at every centre.
NABH-accredited partner network for transplant, TACE, TARE, RFA & SBRT
Where a liver cancer case requires liver transplant for Milan-criteria HCC, TACE or TARE through an interventional radiology suite, percutaneous RFA for small lesions, or SBRT through advanced linear accelerators, CION coordinates the procedure through NABH-accredited partner hospitals with established transplant teams and interventional radiology capability. NABH accreditation ensures audited compliance with patient-safety, infection-control, and clinical-governance protocols. You get specialist procedural capability without leaving the CION pathway.
Cirrhosis surveillance and supportive oncology
HCC patients almost always have underlying cirrhosis or chronic liver disease. Lifelong surveillance imaging and AFP, hepatitis B antiviral therapy management, hepatitis C cure pathway coordination, nutritional support for the cirrhotic patient, ascites and varices management coordination, and psycho-oncology support are all supported within the CION network — with hepatology input via partner specialists where needed. These are not afterthoughts — they decide whether your recovery is uncomplicated or whether a single complication turns into a re-admission.
Tumour-board governance on every liver cancer case
Every liver cancer case at CION is reviewed by the multidisciplinary tumour board before the treatment plan is finalised. The board debates the BCLC stage, Child-Pugh class, performance status, resection candidacy, transplant eligibility against Milan criteria, ablation suitability, embolization indications, radiation suitability, and systemic therapy choice. The board produces a written summary that becomes part of your records — and yours to keep. You can take it to any second opinion, anywhere.
Verifiable, Not Adjectival
CION's institutional numbers
Specifics beat vague claims. Here is the verifiable network footprint behind CION's liver cancer pathway.
| Network metric | CION figure |
|---|---|
| City centres in Hyderabad | 11 |
| Partner centres across Telangana & Andhra Pradesh | 35+ |
| Centres with CT, MRI & PET-CT diagnostics | 6 |
| Day-care infusion bays for systemic therapy | All 11 city centres |
| Cancer specialists on panel | 17+ |
| Patients treated network-wide | 15,000+ |
| Liver cancer cases managed annually | 1,000+ per year |
| Google review rating | 4.8 ★ (800+ reviews) |
| Transplant, TACE, TARE & SBRT partner accreditation | NABH-accredited |
| Tumour-board review on every case (with BCLC staging) | Yes — written summary |
| Written second opinion | Free (worth ₹950) |
| Insurance & ArogyaSri accepted | Yes — empanelled |
| EMI facility for self-paying patients | Available on selected packages |
Every number above is independently verifiable on request — ask any CION specialist for the underlying details.
Financial Accessibility
Insurance, ArogyaSri & cost transparency
Liver cancer treatment ranges from a single TACE session to a liver transplant — financial profiles vary by an order of magnitude. Financial clarity at the start is part of clinical care, not separate from it. CION provides a written, itemised treatment plan and cost estimate before any decision is finalised.
ArogyaSri empanelment
Eligible patients can access state-scheme coverage at empanelled CION centres. The ArogyaSri coordinator handles paperwork directly.
Cashless insurance
Most major insurers and TPAs are accepted, with pre-authorisation handled by the CION insurance desk.
EMI facility
Available for self-paying patients on selected treatment packages — surgery, locoregional procedures, and systemic therapy.
Written cost estimate
Surgery, ablation, embolization, transplant referral, systemic therapy, and supportive care are itemised before treatment begins.
Transplant and TARE in particular have specific scheme rules. The CION insurance desk will confirm coverage and pre-authorisation requirements before your treatment begins. Ask for written confirmation.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Frequently Asked Questions About Choosing a Liver Cancer Hospital in Hyderabad
Which is the best liver cancer hospital in Hyderabad?
No single hospital is automatically best — the right answer depends on whether you have HCC or cholangiocarcinoma, your BCLC stage, your liver function, and whether you are a transplant candidate. Look for a multidisciplinary team trained in hepatobiliary oncology, NCCN protocols, multi-phase imaging with LI-RADS reporting, interventional radiology capability for TACE/RFA/TARE via NABH-accredited partners, a transplant pathway, and day-care systemic therapy. CION Cancer Clinics meets these criteria with 11 centres across Hyderabad and 1,000+ liver cancer cases managed every year.
How do I choose the right liver cancer hospital in Hyderabad?
Verify eight signals in writing: hepatobiliary-trained multidisciplinary team, tumour-board review on every case with BCLC staging, annual hepatectomy volume, multi-phase CT/MRI with LI-RADS reporting and AFP testing, day-care systemic therapy near home, NABH-accredited partners for liver transplant and loco-regional therapy (TACE, TARE, RFA, SBRT), insurance and ArogyaSri empanelment, and continuity for lifelong cirrhosis surveillance.
What is the success rate of liver cancer treatment in Hyderabad?
Outcomes depend on stage and liver function. Per US National Cancer Institute SEER data, 5-year relative survival for liver cancer is approximately 37% for localised disease, 13% for regional spread, and 4% for distant metastasis. However, for early HCC treated with curative options — resection, ablation, or liver transplant within Milan criteria — 5-year survival commonly reaches 50–70%, and post-transplant survival can exceed 70%. Early diagnosis and a tumour-board-led treatment plan are decisive.
How much does liver cancer treatment cost in Hyderabad?
Costs vary substantially by stage and pathway. Indicative ranges: hepatic resection ₹2–6 lakh; liver transplant ₹18–30 lakh (via NABH-accredited partner); RFA ₹80,000–2 lakh; TACE ₹1–2 lakh per session; TARE / Y-90 SIRT ₹6–10 lakh; SBRT ₹2–4 lakh; atezolizumab + bevacizumab ₹2–4 lakh per cycle; lenvatinib ₹40,000–60,000 per month. CION provides a written treatment plan and itemised cost estimate before treatment begins, with an EMI facility available on selected packages.
Should I choose a cancer-specialty hospital or a multi-specialty hospital for liver cancer?
A cancer-specialty hospital or network usually offers tighter oncology workflows — tumour-board review with BCLC staging, dedicated chemo and immunotherapy day-care, oncology-trained nursing, and faster access to medical, surgical, and radiation oncology. A multi-specialty general hospital with an in-house transplant program and hepatology service may be the better fit for transplant candidates or for patients with advanced cirrhosis needing cross-speciality support. For most HCC and ICC patients without imminent transplant need, the cancer-specialty pathway with NABH-accredited partners for transplant and loco-regional therapy is the structural fit.
Is TACE, RFA, or TARE available for liver cancer in Hyderabad?
Yes. Loco-regional therapies — radiofrequency ablation (RFA) for small HCCs, transarterial chemoembolization (TACE) for intermediate-stage HCC, and transarterial radioembolization (TARE / Y-90 SIRT) for selected cases — are available in Hyderabad through centres with interventional radiology capability. CION coordinates RFA, TACE, and TARE through NABH-accredited partner hospitals with the same CION oncology team overseeing the case.
Is liver transplant available for liver cancer in Hyderabad?
Yes. Liver transplant is available in Hyderabad at select centres with established transplant programs. CION coordinates transplant evaluation and surgery through NABH-accredited partner hospitals with active liver transplant teams. Eligibility typically follows the Milan criteria — single tumour up to 5 cm, or up to 3 tumours each up to 3 cm, without vascular invasion or extrahepatic spread. Your CION tumour board reviews transplant candidacy as part of the treatment plan.
Do liver cancer hospitals in Hyderabad accept ArogyaSri and private insurance?
Many qualified hospitals are empanelled for ArogyaSri and most major cashless insurers — but empanelment varies by centre and by procedure. Liver transplant in particular has specific scheme rules. CION Cancer Clinics is empanelled for ArogyaSri and accepts most major cashless insurance providers and TPAs. Request a written cost estimate and confirm pre-authorisation before treatment begins, especially for transplant and TARE.
Are liver cancer hospitals in Hyderabad NABH accredited?
Several Hyderabad hospitals hold NABH accreditation — the Indian healthcare quality standard covering patient safety, infection control, and clinical governance. CION's partner hospitals for liver transplant, TACE, TARE / Y-90 SIRT, and SBRT are NABH-accredited, giving patients audited assurance on infection control and surgical safety for these complex procedures.
What facilities should I check before admitting for liver cancer surgery?
Confirm in writing: dedicated hepatobiliary OT, multi-phase CT/MRI with LI-RADS reporting, AFP turnaround, ICU with hepatic-failure management capability, blood-bank access for major hepatectomy, interventional radiology suite or NABH-accredited partner pathway for TACE/RFA/TARE, transplant pathway via NABH-accredited partner if needed, in-house or networked chemo day-care for systemic therapy, room categories, and your surgeon's annual hepatectomy case volume.
Choose a hospital built for liver cancer — not one that just treats it.
Book a free 45-minute consultation with a senior CION oncologist. Tumour-board review, BCLC staging, written second opinion — yours to keep and take anywhere.
Medical Disclaimer: The information on this page is provided for general educational purposes and reflects current clinical practice in liver cancer oncology at the time of last medical review. It is not a substitute for individual medical advice, diagnosis, or treatment. Treatment decisions, drug choices, dosing, surgical approach, and follow-up schedules must be made by a qualified physician evaluating the specific patient. Survival statistics cited are population-level estimates drawn from public registries and do not predict outcomes for an individual case. Always discuss your specific situation with a qualified medical or surgical oncologist before acting on any information presented here.
Last Medically Reviewed: May 2026 by Dr. Muralidhar Muddusetty — Surgical Oncologist, MBBS (AIIMS), MS Surgery (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)